This Article Full Text Full Text (PDF) CME: Take the course for this article: Multiple Management Modalities in Esophageal Cancer: Epidemiology, Presenta... eLetters: Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article link to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Koshy, M. Articles by Matthews, R. H. Search for Related Content PubMed PubMed Citation Articles by Koshy, M. Articles by Matthews, R. H.

Multiple Management Modalities in Esophageal Cancer: Epidemiology, Presentation and Progression, Work-up, and Surgical Approaches

^a Emory University School of Medicine, Department of Radiation Oncology, Atlanta, Georgia, USA; ^b UTHSCSA/San Antonio Cancer Institute, Department of Radiation Oncology, San Antonio, Texas, USA; ^c Beth Israel/Deaconess Medical Center, Harvard Medical School, Department of Radiation Oncology, Boston, Massachusetts, USA; ^d Boston VA Health Care Radiation Oncology Service, Boston, Massachusetts, USA

Correspondence: Richard H. Matthews, M.D., Ph.D., Beth Israel/Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, Massachusetts 02215, USA. Telephone: 617-232-9500, ext 4457 or ext 5628; Fax: 617-524-0643; e-mail: RHMatthews{at}comcast.net

Annually, approximately 13,200 people in the U.S. are diagnosed with esophageal cancer and 12,500 die of this malignancy. Of new cases, 9,900 occur in men and 3,300 occur in women. In part I of this two-part series, we explore the epidemiology, presentation and progression, work-up, and surgical approaches for esophageal cancer. In the 1960s, squamous cell cancers made up greater than 90% of all esophageal tumors. The incidence of esophageal adenocarcinomas has risen considerably over the past two decades, such that they are now more prevalent than squamous cell cancer in the western hemisphere. Despite advances in therapeutic modalities for this disease, half the patients are incurable at presentation, and overall survival after diagnosis is grim. Evolving knowledge regarding the etiology of esophageal carcinoma may lead to better preventive methods and treatment options for early stage superficial cancers of the esophagus. The use of endoscopic ultrasound and the developing role of positron emission tomography have led to better diagnostic accuracy in this disease. For years, the standard of care for esophageal cancer has been surgery; there are several variants of the surgical approach. We will discuss combined modality approaches in part II of this series.

Key Words. Esophageal carcinoma • Multimodal treatment • Survival • Surgeries

This article has been cited by other articles:

				H. Zhang, L. Xu, D. Xiao, J. Xie, H. Zeng, Z. Wang, X. Zhang, Y. Niu, Z. Shen, J. Shen, et al. Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion J. Clin. Pathol., May 1, 2007; 60(5): 555 - 561. [Abstract] [Full Text] [PDF]

				J S Nagabhushan, S Srinath, F Weir, W J Angerson, B A Sugden, and C G Morran Comparison of P-POSSUM and O-POSSUM in predicting mortality after oesophagogastric resections Postgrad. Med. J., May 1, 2007; 83(979): 355 - 358. [Abstract] [Full Text] [PDF]

				J. B. Maxhimer, R. M. Reddy, J. Zuo, G. W. Cole Jr, D. S. Schrump, and D. M. Nguyen Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein kinase C inhibitor (calphostin C) J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 53 - 63. [Abstract] [Full Text] [PDF]

				M. Koshy, N. Esiashvilli, J. C. Landry, C. R. Thomas Jr., and R. H. Matthews Multiple Management Modalities in Esophageal Cancer: Combined Modality Management Approaches Oncologist, April 1, 2004; 9(2): 147 - 159. [Abstract] [Full Text] [PDF]